Clinical Trial Update: Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the effects of Botulinum Toxin A on peripheral pain mechanisms in temporomandibular disorders and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorders

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Karolinska Institutet | Conditions: Temporomandibular Disorders | Phase 2 | Status: RECRUITING